Cell & Gene Therapy

Passage Bio Announces Gene Therapy Manufacturing Research and Development Site

Passage Bio | GlobeNewswire

PHILADELPHIA, Dec. 16, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced that it has entered into a long-term lease to support Chemistry, Manufacturing and Controls (CMC) laboratory operations for the company’s gene therapy programs. The new laboratory, slated to open …

BioCentriq opens at NJII: ‘This is a complete game-changer for N.J.’

Tom Bergeron | ROI-NJ

Cutting-edge cell and gene therapy development and clinical manufacturing center could be leader in finding cures — attracting more bio companies to state New Jersey Institute of Technology President Joel Bloom said BioCentriq is the type of company the school had in mind when it created the New Jersey Innovation Institute in 2015 as a platform for collaboration and partnerships with industry and governmental agencies. …

Ori Biotech To Use $30M Series A On Cell, Gene Therapy Manufacturing Platform

Christine Hall | Crunchbase

The drug discovery pipeline can take, on average, a decade to get from the lab to the patient. Ori Biotech aims to speed up the innovation of cell and gene therapies via the manufacturing platform it is bringing to market. The London and Woodcliff Lake, New Jersey-based company is developing a platform that closes, automates and standardizes manufacturing for cell and gene …

Innovating During COVID-19: New Jersey’s Next Era in Life Sciences

Choose New Jersey | Area Development

Following 150 years of global leadership in life sciences, cell and gene therapy (CGT) is rapidly accelerating within the New Jersey ecosystem. As winter began to wane this year, the world was upended by the COVID-19 pandemic. Unprecedented levels of interest in cell and gene therapies have followed, with research and development (R&D) facilities testing different potential solutions, such as …

New Jersey Solutions For Cell And Gene Development and Manufacturing

Louis Garguilo | Outsourced Pharma

New Jersey’s first university-based, cell-and-gene-therapy development and manufacturing innovation center for-hire, was founded on the answers to these questions of the biopharma industry: What are your main challenges in manufacturing gene and cell therapy products? What are your challenges in recruiting talent? What do you need to effectively train your current employees? Answers poured in pre-establishment of the center from …

Attracting Tech Companies – A NJ Success Story

Joe Cavaluzzi | New Jersey Business Magazine

Best-educated workforce, IT infrastructure, strong base of life sciences and fintech talent drawing companies to the Garden State. New Jersey boasts the highest concentration of scientists and engineers per square mile in the United States – tied with Massachusetts. Add numerous technology partnerships with top universities and a growing number of community college and high school, vocational tech, and advanced …

Novartis Inks Deal to Make Experimental Coronavirus Vaccine

Denise Roland | The Wall Street Journal

Swiss drugmaker will make gene-based Covid-19 vaccine being developed at Massachusetts Eye and Ear, Massachusetts General Hospital and University of Pennsylvania Novartis AG has agreed to manufacture a gene-based coronavirus vaccine being developed by scientists at Massachusetts Eye and Ear hospital, Massachusetts General and the University of Pennsylvania, paving the way for human testing to begin later this year. The Swiss drugmaker’s …

BioCentriq Name of First Cell and Gene Therapy Development and Manufacturing Center Located on a University Campus in the U.S.

Joseph D'Allegro | New Jersey Innovation Institute

Today the Biopharma Division of the New Jersey Innovation Institute (NJII), an NJIT corporation, introduced BioCentriq as the name of its cell and gene therapy production and manufacturing center. BioCentriq is the only process development and clinical manufacturing facility for cell and gene therapies located in Newark, N.J., and the first of its kind to be located on a university …

FDA Green-Lights Clinical Trial For COVID-19 Coronavirus Treatment That ‘Flattens The Curve’ In Patients

Alex Knapp | Forbes

Therapeutics startup Celularity announced Thursday morning that it has received FDA clearance to begin a clinical trial of a proposed stem-cell treatment for COVID-19. The approval of the New Jersey-based company’s IND application enables the company to begin a clinical trial with patients who have the disease. The company’s therapy, called CYNK-001 for now, uses “Natural Killer” (NK) cells, a form of …

WHAT CAN CHOOSE New Jersey DO FOR YOU

Relocation & Expansion Services

We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.

Site Visits

We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.

Economic Development Connections

Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.

Carly Wronko
Director of Creative & Digital Marketing
Tiffany Hess-Bennette
Creative Content Specialist